BR9605437A - 2-(aminometil)-3,4,7,9-tetraido-2-h-pirano-(2,3-e)indo l-8-onas e derivados - Google Patents

2-(aminometil)-3,4,7,9-tetraido-2-h-pirano-(2,3-e)indo l-8-onas e derivados

Info

Publication number
BR9605437A
BR9605437A BR9605437A BR9605437A BR9605437A BR 9605437 A BR9605437 A BR 9605437A BR 9605437 A BR9605437 A BR 9605437A BR 9605437 A BR9605437 A BR 9605437A BR 9605437 A BR9605437 A BR 9605437A
Authority
BR
Brazil
Prior art keywords
tetraido
indo
pyran
aminomethyl
ones
Prior art date
Application number
BR9605437A
Other languages
English (en)
Other versions
BR9605437B1 (pt
Inventor
Gary Paul Stack
Richard Eric Mewshaw
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9605437A publication Critical patent/BR9605437A/pt
Publication of BR9605437B1 publication Critical patent/BR9605437B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI9605437-9A 1995-11-06 1996-11-06 2-(aminometil)-3,4,7,9-tetraido-2-h-pirano-[2,3-e] indol-8-onas e derivados, bem como composição farmacêutica compreendendo os mesmos. BR9605437B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US730795P 1995-11-06 1995-11-06

Publications (2)

Publication Number Publication Date
BR9605437A true BR9605437A (pt) 1998-08-04
BR9605437B1 BR9605437B1 (pt) 2009-08-11

Family

ID=21725405

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9605437-9A BR9605437B1 (pt) 1995-11-06 1996-11-06 2-(aminometil)-3,4,7,9-tetraido-2-h-pirano-[2,3-e] indol-8-onas e derivados, bem como composição farmacêutica compreendendo os mesmos.

Country Status (23)

Country Link
EP (1) EP0771801B1 (pt)
JP (1) JPH09169764A (pt)
KR (1) KR970027086A (pt)
CN (1) CN1083843C (pt)
AR (1) AR004523A1 (pt)
AT (1) ATE177102T1 (pt)
AU (1) AU701636B2 (pt)
BR (1) BR9605437B1 (pt)
CA (1) CA2189525C (pt)
CZ (1) CZ286649B6 (pt)
DE (1) DE69601611T2 (pt)
DK (1) DK0771801T3 (pt)
ES (1) ES2128145T3 (pt)
GR (1) GR3030132T3 (pt)
HK (1) HK1010104A1 (pt)
HU (1) HUP9603058A3 (pt)
IL (1) IL119483A (pt)
MX (1) MX9605369A (pt)
NO (1) NO964684L (pt)
NZ (1) NZ299680A (pt)
SK (1) SK281085B6 (pt)
TW (1) TW467914B (pt)
ZA (1) ZA969191B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4091797A (en) * 1996-08-27 1998-03-19 American Home Products Corporation 4-aminoethoxy-indolone derivatives as dopamine d2 agonists
DE69722020T2 (de) * 1996-10-15 2004-01-22 Wyeth Azaheterocyclylmethyl-derivate von 2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-on
HUP0001262A3 (en) * 1997-02-18 2002-04-29 American Home Products Corp Ma 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one deriatives, their preparation and their use as dopamine autoreceptor (d2) agonists
US5990144A (en) * 1997-02-18 1999-11-23 American Home Products Corporation 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autoreceptor agonists
US6541501B2 (en) 2001-07-20 2003-04-01 Wyeth 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
US6541502B1 (en) * 2001-07-20 2003-04-01 Wyeth 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
TW200811182A (en) 2006-05-25 2008-03-01 Wyeth Corp Oxindoledioxans, synthesis thereof, and intermediates thereto

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314944A (en) 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
DE4135474A1 (de) 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
DE4140540A1 (de) 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
SI0707007T1 (en) * 1994-10-14 2002-04-30 Merck Patent Gmbh (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent

Also Published As

Publication number Publication date
HU9603058D0 (en) 1996-12-30
KR970027086A (ko) 1997-06-24
ATE177102T1 (de) 1999-03-15
CN1151989A (zh) 1997-06-18
SK281085B6 (sk) 2000-11-07
MX9605369A (es) 1997-05-31
NO964684L (no) 1997-05-07
IL119483A0 (en) 1997-01-10
CZ324096A3 (en) 1997-12-17
HK1010104A1 (en) 1999-06-11
CA2189525C (en) 2006-04-25
IL119483A (en) 1999-06-20
EP0771801A1 (en) 1997-05-07
NZ299680A (en) 1998-05-27
EP0771801B1 (en) 1999-03-03
JPH09169764A (ja) 1997-06-30
ZA969191B (en) 1998-04-30
GR3030132T3 (en) 1999-07-30
CN1083843C (zh) 2002-05-01
HUP9603058A2 (en) 1997-05-28
ES2128145T3 (es) 1999-05-01
SK141396A3 (en) 1997-05-07
DE69601611T2 (de) 1999-10-21
CZ286649B6 (cs) 2000-05-17
BR9605437B1 (pt) 2009-08-11
HUP9603058A3 (en) 1998-12-28
DK0771801T3 (da) 1999-09-27
DE69601611D1 (de) 1999-04-08
TW467914B (en) 2001-12-11
CA2189525A1 (en) 1997-05-07
AR004523A1 (es) 1998-12-16
AU7055496A (en) 1997-05-15
AU701636B2 (en) 1999-02-04
NO964684D0 (no) 1996-11-05

Similar Documents

Publication Publication Date Title
ATE340176T1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
NL300214I2 (nl) Chinazolinederivaten.
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
DK0991658T3 (da) Dolastatin 15-derivater
TR199600883A2 (tr) Pürin-6-on türevleri.
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
NO970740D0 (no) Glutamat reseptor
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
BR9609884A (pt) N-aril- 1,2,4-triazolin-5-onas
DE69618634D1 (de) 1,4-benzodioxin-derivate
TR199600715A2 (tr) Kefalosforin türevleri.
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
BR9605437A (pt) 2-(aminometil)-3,4,7,9-tetraido-2-h-pirano-(2,3-e)indo l-8-onas e derivados
NO961404D0 (no) 4-indolylpiperazinyl-derivater
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
NO973624D0 (no) Vasokonstriktive substituerte 2,3-dihydro-1,4-dioksinopiperidiner
MA26481A1 (fr) Derives d'arylsecocholadiene
NO962931D0 (no) N,N-Dietyl-8,8-dipropyl-2-azaspiro[4,5Ådecan-2-propanamindimaleat
PT887349E (pt) Derivados de tetra-hidro-imidazo¬2,1-a|isoquinolina
BR9610047A (pt) 1,3,4-oxadiazolin-2-onas
FI952912A0 (fi) Traedcylinder, gripelement med traedrotsprincip
ES1032746Y (es) Futbolin perfeccionado.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO POR INCIDENCIA NOS ARTIGOS 24 E 25 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09Y Publication of grant cancelled [chapter 9.1.2 patent gazette]

Free format text: REFERENTE A RPI 1982 DE 30/12/2008.

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/08/2009, OBSERVADAS AS CONDICOES LEGAIS.

B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 14A ANUIDADE(S).

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AO NAO CUMPRIMENTO DA EXIGENCIA, RPI 2107 DE 24/05/2011 E NAO RECOLHIMENTO DA 14A E 15A ANUIDADES.